510(k) Report

510(k) · Cleared

Cleared

Pascal Medical AB Meniett 20

K991562510(k) TraditionalCleared Dec 28, 1999238-day reviewClass II21 CFR 874.1090

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Pascal Medical AB · ETY Tester, Auditory Impedance

Cleared on Dec 28, 1999 as substantially equivalent to K822745 (American Electromedics Corp., 1982) after a 238-day review. Its family tree reaches back 1 generation to 1982.

Decided
Dec 28, 1999
Review
238 days
Class
Class II
Product code
ETY
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K822745 (1982). No later device cites it as a predicate yet.

K822745 · The Screening Tympanometer · American Electromedics Corp. · 198219801985199019952000
  1. Root · 1 generation backK822745 The Screening TympanometerAmerican Electromedics Corp. · 1982
  2. This deviceK991562 Pascal Medical AB Meniett 20Pascal Medical AB · 1999
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K822745The Screening TympanometerAmerican Electromedics Corp.1982—
0 (this device)K991562Pascal Medical AB Meniett 20Pascal Medical AB1999—
FIG. 1 — Lineage of K991562, 1982–1999Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in ETY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K822745The Screening Tympanometer
Our OCR of the scanned summary read K822475, FDA’s number for Total Protein Standard, #65074 (Emd Chemicals, Inc.). Corrected to the number with two digits swapped whose FDA name carries the summary’s words for the device, “American Electromedics Corporation Screening Tympanometer”.
American Electromedics Corp.1982—
*—Hyper/Hypobaric pressure chambers
Named without a submission number
—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All ETY devices

ETY Tester, Auditory Impedance: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · ETY

1in 2019

2007: 12008: 12009: 12012: 12014: 12015: 22016: 22017: 12019: 1
2007high 2 (2015) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · ETY

Too few ETY 510(k)s in any year since 2007 to give a median.

Recalls per year · ETY

No recall names ETY since 2007.

Adverse event reports per year · ETY

1in 2025

2011: 12013: 12021: 12024: 12025: 1
2007high 1 (2011) · low 0 (2007)2025

MAUDE reports naming product code ETY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20081—00
20091—00
20100—00
20110—01
20121—00
20130—01
20141—00
20152—00
20162—00
20171—00
20180—00
20191—00
20200—00
20210—01
20220—00
20230—00
20240—01
20250—01
20260—0—

What is it indicated for?

Meniett 20 is indicated for symptomatic treatment of Meniére’s disease. The therapeutic effect of Meniett 20 is achieved by applying low frequency, low amplitude pressure pulses to the middle ear whereby inner ear endolymphatic fluids are assumed to be evacuated from the cochlea and thus relieve the patient of the symptoms associated with endolymphatic hydrops.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K991562: Pascal Medical AB Meniett 20.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K991562

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026